Complement activation in acquired and hereditary amyloid neuropathy

Journal of the Peripheral Nervous System

Volumn 5, Issue 3, 2000, Pages 131-139

  Hafer Macko, Charlene E ^a   Dyck, Peter J ^b   Koski, Carol Lee ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Acquired amyloidosis; Complement; Hereditary amyloidosis; Immunohistochemistry; Peripheral neuropathy

Indexed keywords

COMPLEMENT;

ADULT; AGED; AMYLOID NEUROPATHY; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE FIBER DEGENERATION; NERVE INJURY; PATHOGENESIS; PERIPHERAL NERVE; PRIORITY JOURNAL; SURAL NERVE;

AGED; AMYLOIDOSIS; BIOPSY; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT C3D; COMPLEMENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; SURAL NERVE;

EID: 0033808143     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8027.2000.00018.x     Document Type: Article

References (32)

1. Complement-dependent pro-inflammatory properties of the Alzheimer's disease beta-peptide
2. 2+
3. Primary amyloidosis with a special reference to involvement of nervous system
4. Sublytic terminal complement complexes decrease protein zero expression in Schwann cells
5. Terminal complement complexes concomittantly stimulate proliferation and rescue of Schwann cells from apoptosis
6. Dibutyryl cyclic AMP and inflammatory cytokines mediate C3 expression in Schwann cells
7. Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages
8. Dissociated sensation in amyloidosis: Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies
9. Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells
10. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
11. Beta-amyloid activates complement by binding to a specific region of collagen-like domain of the C1 q A chain
12. Amyloid neuritis
13. Complement regulatory molecules on human myelin and glial cells: Differential expression affects deposition of activated complement proteins
14. Activation of the alternative pathway of complement by human peripheral nerve myelin
15. Cytolysis of nucleated cells by complement: Cell death displays multi-hit characteristics
16. Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy
17. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
18. Complement proteins and complement inhibitors in Alzheimer's disease
19. Recovery of human neutrophils from complement attack: Removal of membrane attack complex by endocytosis and exocytosis
20. Multifocal motor neuropathy human sera blocks distal motor nerve conduction in mice
21. Complement activation by beta-amyloid in Alzheimer's disease
22. Transient perturbations of endothelial integrity induced by natural antibodies and complement
23. CD59 homologue regulates complement dependent cytolysis of rat Schwann cells
24. Enhanced cytotoxicity of beta-amyloid peptide by a complement dependent mechanism
25. Amyloid neuropathy: Immuno-cytochemical localization of intra- and extracellular immuno-globulin light chains
26. Amyloid polyneuropathy
27. Familial amyloid polyneuropathy associated with transthyretin Gly42 mutation: A quantitative light and electron microscopic study of the peripheral nervous system
28. Amyloidosis with plasma cell dyscrasia
29. Hydrolysis of myelin basic protein in human myelin by terminal complement complexes
30. Enhanced aggregation and beta structure of amyloid beta peptide after coincubation with C1q
31. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen like region of C1q
32. Complement neoantigen and vitronectin are components of plaques in amyloid polyneuropathy